Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.

European urology oncology·2026
Same author

Correction: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.

Oncogene·2026
Same author

Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.

Actas urologicas espanolas·2026
Same author

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Impact of opium on bladder cancer incidence: A systematic review and meta-analysis.

Actas urologicas espanolas·2025
Same author

Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review.

Actas urologicas espanolas·2025

Related Experiment Video

Updated: Jun 28, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Screening for bladder cancer using urine-based tumor markers.

R S Svatek1, Y Lotan, P I Karakiewizc

  • 1Department of Urologic Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|October 17, 2008
PubMed
Summary

Bladder cancer screening using urine markers shows promise for early detection, potentially reducing mortality. However, widespread adoption requires evidence of effectiveness and careful financial consideration.

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Related Experiment Videos

Last Updated: Jun 28, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Area of Science:

  • Urology
  • Oncology
  • Biomarker Discovery

Background:

  • Bladder cancer screening aims to reduce mortality by detecting disease early, before symptoms arise.
  • Urothelial carcinoma of the bladder presents unique opportunities for screening due to a defined target population and survival rates linked to early stage detection.

Purpose of the Study:

  • To review the current literature on bladder cancer screening utilizing urine-based markers.
  • To evaluate the potential of urine markers for early detection of urothelial carcinoma.

Main Methods:

  • Literature review of studies investigating urine-based markers for bladder cancer detection.
  • Analysis of the biological basis and diagnostic potential of identified urine markers.

Main Results:

  • Recent advancements in understanding bladder cancer biology have led to the identification of promising urine-based markers.
  • Theoretical feasibility of quick, easy, and painless screening tests using tumor markers is supported by direct cancer cell exposure to urine.

Conclusions:

  • While promising urine-based markers exist for bladder cancer detection, widespread screening program adoption is cautioned against without established evidence of effectiveness.
  • Large-scale financial implications and the need for robust evidence are critical considerations before implementing bladder cancer screening programs.